Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
24.42
-0.24 (-0.97%)
At close: May 30, 2025, 4:00 PM
24.42
0.00 (-0.01%)
After-hours: May 30, 2025, 4:21 PM EDT
Phibro Animal Health Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Phibro Animal Health stock ranges from a low of $15 to a high of $22. The average analyst price target of $20 forecasts a -18.10% decrease in the stock price over the next year.
Price Target: $20.00 (-18.10%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Phibro Animal Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 2 | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | -14.00% | May 8, 2025 |
Barclays | Barclays | Sell Maintains $20 → $22 | Sell | Maintains | $20 → $22 | -9.91% | Feb 10, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $25 | Hold | Maintains | $20 → $25 | +2.38% | Dec 17, 2024 |
Barclays | Barclays | Sell Maintains $13 → $20 | Sell | Maintains | $13 → $20 | -18.10% | Nov 12, 2024 |
JP Morgan | JP Morgan | Hold Initiates $22 | Hold | Initiates | $22 | -9.91% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
1.31B
from 1.02B
Increased by 28.33%
Revenue Next Year
1.49B
from 1.31B
Increased by 13.78%
EPS This Year
2.09
from 0.06
Increased by 3,405.57%
EPS Next Year
2.33
from 2.09
Increased by 11.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.3B | 1.6B | 1.6B | ||
Avg | 1.3B | 1.5B | 1.5B | ||
Low | 1.3B | 1.4B | 1.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 32.6% | 18.8% | 7.3% | ||
Avg | 28.3% | 13.8% | 4.2% | ||
Low | 22.8% | 7.7% | 0.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.16 | 2.48 | 2.79 |
Avg | 2.09 | 2.33 | 2.71 |
Low | 2.00 | 2.16 | 2.61 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3,526.3% | 18.5% | 20.1% |
Avg | 3,405.6% | 11.2% | 16.7% |
Low | 3,251.7% | 3.1% | 12.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.